Product NDC: | 0591-3798 |
Proprietary Name: | Ipratropium Bromide |
Non Proprietary Name: | Ipratropium Bromide |
Active Ingredient(s): | .5 mg/2.5mL & nbsp; Ipratropium Bromide |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-3798 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075693 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110301 |
Package NDC: | 0591-3798-30 |
Package Description: | 1 POUCH in 1 CARTON (0591-3798-30) > 30 VIAL in 1 POUCH > 2.5 mL in 1 VIAL |
NDC Code | 0591-3798-30 |
Proprietary Name | Ipratropium Bromide |
Package Description | 1 POUCH in 1 CARTON (0591-3798-30) > 30 VIAL in 1 POUCH > 2.5 mL in 1 VIAL |
Product NDC | 0591-3798 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ipratropium Bromide |
Dosage Form Name | SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20110301 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | IPRATROPIUM BROMIDE |
Strength Number | .5 |
Strength Unit | mg/2.5mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |